baber/WOPTO huggingface dataset:
Patent AU-2006202341-B2 (AU)
Title: Methods and compositions for prolonging elimination half-times of bioactive compounds
Inventor: LOWMAN HENRY B
IPC: C07K7/08
Filed: 2006-06-01
Granted: 2009-02-19
Abstract: Peptide ligands having affinity for IgG or for serum albumin are disclosed. Also disclosed are hybrid molecules comprising a peptide ligand domain and an active domain. The active domain may comprise any molecule having utility as a therapeutic or diagnostic agent. The hybrid molecules of the invention may be prepared using any of a number techniques including production in and purification from recombinant organisms transformed or transfected with an isolated nucleic acid encoding the hybrid molecule, or by chemical synthesis of the hybrid. The hybrid molecules have utility as agents to alter the elimination half-times of active domain molecules. Elimination half-time is altered by generating a hybrid molecule of the present invention wherein the peptide ligand has binding affinity for a plasma protein. In a preferred embodiment, a bioactive molecule having a short elimination half-time is incorporated as or into an active domain of the hybrid molecules of the invention, and the binding affinity of the peptide ligand domain prolongs the elimination half-time of the hybrid as compared to that of the bioactive molecule.
Patent AU-2006226120-B2 (AU)
Title: Antigen detection
Inventor: COLIN CAMPBELL
IPC: G01N33/80
Filed: 2006-03-23
Granted: 2011-08-18
Abstract: The present invention relates to methods of detecting specific cell surface antigens present in a sample of cells being tested and in particular blood group antigens, which methods do not employ the addition of extrinsic labels to detect said cell surface antigens. Typically detection is carried out using an intrinsic fluorescence capability of the cells being tested.
Patent AU-2006226750-B2 (AU)
Title: Method of treating skin ulcers using oxidative reductive potential water solution
Inventor: GUTIERREZ ANDRES
IPC: A61P17/02
Filed: 2006-03-23
Granted: 2012-07-19
Abstract: Provided is a method of treating skin ulcers and related complications in patients by administering an oxidative reduction potential (ORP) water solution that is stable for at least twenty-four hours.
Patent AU-2006244447-B2 (AU)
Title: Token sharing system and method
Inventor: DAVID M RAIHI
IPC: G06F7/04
Filed: 2006-05-05
Granted: 2011-08-18
Abstract: A scalable system and method for authenticating entities such as consumers to entities with a diverse set of authentication requirements, such as merchants, banks, vendors, other consumers, and so on. An authentication credential such as a token can be shared among several resources as a way to authenticate the credential owner.
Patent AU-2006286466-B2 (AU)
Title: Adaptive user interface for rock drilling rig
Inventor: HEIKKI SAHA
IPC: G06F3/0484
Filed: 2006-08-29
Granted: 2011-07-14
Abstract: The invention relates to a control apparatus for controlling a multi-phase rock drilling event carried out with a rock drilling rig. In a display of the rock drilling rig or a control unit thereof, a first section is settable for substantially invariable information sources and a second section for information sources to be changed according to the rock drilling situation, and a definition is set rock drilling situation-specifically in the control apparatus about at least one information source, information relating to which is to be displayed in said rock drilling situation. The working phase of the rock drilling event is checked (400), and an information source suitable for said phase is selected on the basis of said definition (402). Information relating to the at least one selected information source is displayed (406) in said display part during execution of the rock drilling phase.
Patent AU-2006330078-B2 (AU)
Title: Aspiration system for ophthalmic medical devices
Inventor: ALEX URICH
IPC: A61F9/007
Filed: 2006-08-16
Granted: 2012-01-12
Abstract: An ophthalmic aspiration system that can be used with a hand piece and a vacuum source. The aspiration system includes a first tube that is connected to the hand piece and a second tube that is connected to a vacuum source. A filter assembly is connected to both tubes to filter out particles aspirated into the system. The second tube has an inner diameter smaller than an inner diameter of the first tube. The smaller second tube limits the amount of flow through the system to minimize vacuum surges caused by occlusions.
Patent AU-2007221748-B2 (AU)
Title: Method for attenuating particle motion sensor noise in dual sensor towed marine seismic streamers
Inventor: SOLLNER WALTER
IPC: G01V1/28
Filed: 2007-10-01
Granted: 2012-09-27
Abstract: Signals detected by particle motion sensors in a towed dual sensor marine seismic streamer are scaled to match signals detected by pressure sensors in the streamer. The pressure sensor signals and the scaled particle motion sensor signals are combined to generate up-going and down-going pressure wavefield components. The up-going and down-going pressure wavefield components are extrapolated to a position just below a water surface. A first matching filter is applied to the extrapolated down-going pressure wavefield component. The filtered down-going pressure wavefield component is subtracted from the extrapolated up-going pressure wavefield component, generating an up-going pressure wavefield component with attenuated particle motion sensor noise. A second matching filter is applied to the extrapolated up-going pressure wavefield component. The filtered up-going pressure wavefield component is subtracted from the extrapolated down-going pressure wavefield component, generating a down-going pressure wavefield component with attenuated particle motion sensor noise.
Patent AU-2007222584-B2 (AU)
Title: Anti-drug antibody assay
Inventor: STUBENRAUCH KAY-GUNNAR
IPC: G01N33/543
Filed: 2007-03-07
Granted: 2012-07-12
Abstract: The invention provides a method for the immunological determination of an antibody against a drug antibody in a sample using a double antigen bridging immunoassay comprising a capture drug antibody and a tracer drug antibody, characterized in that the capture drug antibody is a mixture of said drug antibody conjugated to the solid phase at at least two different antibody sites and the tracer drug antibody is a mixture of said drug antibody conjugated to the detectable label at at least two different antibody sites.
Patent AU-2007224255-B2 (AU)
Title: Fuel processor apparatus and method for a diesel engine
Inventor: NADEAU JR BRUCE E
IPC: F02B19/08
Filed: 2007-03-01
Granted: 2011-06-23
Abstract: The present invention provides a diesel engine and methods and apparatus for premixing diesel fuel and oxidant for combustion. The methods and apparatus may include a two stage vortex, each stage accommodating different flow rate ranges. The vortex pulverizes diesel fuel and optimally mixes the diesel fuel with an oxidant prior to introduction into a combustion chamber. The premixing results in more complete combustion and, consequently, fuel efficiency is increased and pollution is decreased.
Patent AU-2007227062-B2 (AU)
Title: A downhole optic fiber wet connect system and method
Inventor: CORONADO MARTIN P
IPC: G02B6/38
Filed: 2007-03-15
Granted: 2011-07-21
Abstract: A downhole optic fiber wet-connect system includes first and second matable portions of a tool body; first and second matable portions of a connector. Further included is a first magnet associated with one of the first and second matable portions and a second magnet associated with the other of the first and second matable portions, the first and second magnets being oriented to attract one another; a first opening in one of the first and second matable portions of the tool body; a second opening in the other of the first and second matable portions of the tool body; and at least one of the first and second openings in the first and second matable portions of the tool body configured and dimensioned to loosely receive one of the first and second matable portions of the connector therein and a method for wet-connecting an optic fiber in a downhole environment.
Patent AU-2007248226-B2 (AU)
Title: Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
Inventor: MARX JEFFERY C
IPC: A61K38/095
Filed: 2007-04-27
Granted: 2012-11-08
Abstract: The invention provides compositions, kits, and methods for treatment of neuronal injury. In one embodiment, the composition comprises a biomembrane sealing agent, such as PEG, and a bioactive agent, such as a magnesium compound. The biomembrane sealing agent and/or the bioactive agent an intravenous administration, an intramuscular administration, an intrathecal administration, a subcutaneous administration, an epidural administration, a parenteral administration, a direct application onto or adjacent to a site of the pathological condition, and any combinations thereof. Alternatively, the biomembrane sealing agent and/or the bioactive agent may be delivered from a pump or an implant.
Patent AU-2007274056-B2 (AU)
Title: Method for introducing siRNA into cells by photochemical internalisation
Inventor: HOVIG EIVIND JOHANNES
IPC: A61K41/00
Filed: 2007-07-11
Granted: 2013-08-01
Abstract: The present invention relates to a method for introducing an siRNA molecule into the cytosol of a cell, said method comprising i) contacting said cell with an siRNA molecule, a carrier and a photosensiting agent, and ii) irradiating the cell with light of a wavelength effective to activate the photosensitising agent, wherein said carrier comprises a cationic polyamine such as a lipopolyamine in a non-liposomal formulation, polyethyleneimine (PEI), a betacyclodextrin amine polymer, an amine group containing dendrimer, and a cationic peptide. Cells or a population of cells obtainable by the method, a composition containing an siRNA molecule and the carrier molecule, kits and therapeutic uses of the above are also provided.
Patent AU-2007298571-B2 (AU)
Title: Modulating regulatory T cell activity via Interleukin 35
Inventor: WORKMAN CREG
IPC: A61K39/39
Filed: 2007-09-24
Granted: 2012-06-07
Abstract: Methods for regulating T cell function in a subject, particularly regulatory T cell activity are provided. Methods of the invention include administering to a subject a therapeutically effective amount of an Interleukin 35 -specific binding agent, such as an antibody or small molecule inhibitor. The invention further provides methods for enhancing the immunogenicity of a vaccine or overcoming a suppressed immune response to a vaccine in a subject, including administering to the subject a therapeutically effective amount of an IL35-specific binding agent and administering to the subject a vaccine. In one embodiment the vaccine is a cancer vaccine.
Patent AU-2007325698-B2 (AU)
Title: Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same
Inventor: JANKOWSKI RONALD
IPC: A61K35/12
Filed: 2007-11-28
Granted: 2014-03-20
Abstract: The present invention provides muscle-derived progenitor cells that show long-term survival following transplantation into body tissues and which can augment soft tissue following introduction (e.g. via injection, transplantation, or implantation) into a site of soft tissue. Also provided are methods of isolating muscle-derived progenitor cells, and methods of genetically modifying the cells for gene transfer therapy. The invention further provides methods of using compositions comprising muscle-derived progenitor cells for the augmentation and bulking of mammalian, including human, soft tissues in the treatment of various cosmetic or functional conditions, including malformation, injury, weakness, disease, or dysfunction. In particular, the present invention provides treatments and amelioration for dermatological conditions, gastroesophageal reflux, vesico-ureteral reflux, urinary incontinence, fecal incontinence, heart failure, and myocardial infarction.
Patent AU-2008200300-B2 (AU)
Title: Implants with FK506
Inventor: OEPEN RANDOLF VAN
IPC: A61L31/16
Filed: 2008-01-22
Granted: 2011-04-21
Abstract: Implant (A) contains FK506 in chemically bound (covalent or non-covalent) or physically fixed form and optionally at least one other active agent (II). Independent claims are also included for the following: (a) preparation of (A) optionally coated with active agents, and (b) a stent with a polymeric surface including, in chemically bound (covalent or non-covalent) or physically fixed form, at least one physiologically and/or pharmaceutically active agent. ACTIVITY : Vasotropic. MECHANISM OF ACTION : None given in the source material.
Patent AU-2008203291-B2 (AU)
Title: An offset anchoring system
Inventor: DYHRBERG ROGER WR
IPC: B63B22/02
Filed: 2008-07-23
Granted: 2010-11-25
Abstract: An offset anchoring system for anchoring objects to a floor of a body of water includes T-shaped anchor members arranged in a cluster. Each anchor member having an elongate first and second beams. The second beam, having longitudinal ends, extends transverse to the first beam. The first beam being disposable in the floor. The system also includes a coupling member to which the anchor members being coupled at respective longitudinal ends such that the substantially T-shaped anchor members are arranged in a cluster with the coupling member being disposed substantially centrally of the anchor members and with the second beams extending substantially radially of the coupling member. When the first beams are driven into the floor and a load is applied to the coupling member, the load is offset from a longitudinal axis of each the first beam thereby increasing the holding power of the anchoring system.
Patent AU-2008203586-B2 (AU)
Title: Baggage deposit system
Inventor: TAN MICHAEL KIM
IPC: B64F1/36
Filed: 2008-01-07
Granted: 2013-05-02
Abstract: In a device (4) for receiving a piece of baggage (2) for transport, for example at an airport, the device comprises a receiving room (18A) with an infeed opening and a discharge opening. The receiving room is provided with a closing assembly, the closing assembly comprising a closing mechanism (22, 24). The device furthermore comprises a conveyor unit (16, 20) for discharging the piece of baggage from the receiving room through the discharge opening. The closing assembly is equipped at any time to keep at least one or other of the infeed opening and the discharge opening closed. In this way a device according to the invention is equipped to protect deposited baggage from third parties and to prevent persons from following the piece of baggage to the areas not accessible to the public. The present invention also provides a method for receiving a piece of baggage, which method is in accordance with the functioning of the above-mentioned device.
Patent AU-2008246215-B2 (AU)
Title: Nucleic acid and corresponding protein entitled 238P1B2 useful in treatment and detection of cancer
Inventor: MORRISON ROBERT KENDALL
IPC: C07K14/47
Filed: 2008-11-14
Granted: 2012-02-09
Abstract: A novel gene (designated 238P1 B) and its encoded protein, and variants thereof, are described wherein 238P1 B2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 238PL1B2 provides a diagnostic, prognostic, prophylactic 5 and/or therapeutic target for cancer. The 238P1 B2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 238P1B2 can be used in active or passive immunization.
Patent AU-2008292339-B2 (AU)
Title: Method for imparting stress tolerance to plant
Inventor: KAMEI MASATOSHI
IPC: A01G7/06
Filed: 2008-08-28
Granted: 2012-07-26
Abstract: Disclosed is a method for imparting stress tolerance to a plant, which can provide a plant with such stress tolerance that accelerates the growth of the plant under the environment where various stresses to the plant may occur. The method comprises the step of applying a plant stress tolerance-imparting composition to a plant that is placed under the cultivation conditions receiving a stress at a percentage plant stress of 111 to 200%, wherein the plant stress tolerance-imparting composition comprises a sugar derivative type of surfactant and water. In the plant stress tolerance-imparting composition, the sugar derivative type of surfactant comprises at least one sugar derivative type of surfactant having a structure selected from the group consisting of an ester of a sugar and a fatty acid, an ester of a sugar alcohol and a fatty acid, and an alkyl glycoside. The sugar derivative type of surfactant is contained in the composition in an amount of 85 to 100 wt% relative to the total amount of the components other than water contained in the composition.
Patent AU-2008302214-B2 (AU)
Title: Inhibition of angiogenesis
Inventor: WU XIUMIN
IPC: A61P35/00
Filed: 2008-09-19
Granted: 2012-10-25
Abstract: The present invention relates generally to the inhibition of inflammatory cell-mediated angiogenesis. In particular, the invention concerns the prevention or treatment of tumor angiogenesis, and the inhibition of tumor development, using Bv8 antagonists, such as anti-Bv8 antibodies.
Patent AU-2008322587-B2 (AU)
Title: Utilizing restriction codes in wireless access point connection attempts
Inventor: AGASHE PARAG A
IPC: H04W48/16
Filed: 2008-11-13
Granted: 2012-08-02
Abstract: Systems and methodologies are described that facilitate utilizing restriction codes in rejecting connection requests with restricted association access points to indicate a reason for the rejection. Mobile devices can maintain a list of accessible access points and/or groups of access points, which can be consulted during cell reselection to ensure unsuitable restricted association access points are not utilized in cell reselection. Based on receiving a rejection code from a restricted association access point, a mobile device can remove the access point, or a related group, from its maintained list so that subsequent reselection attempts avoid the access point and/or access points in the related group.
Patent AU-2008322629-B2 (AU)
Title: Dilute filtration sterilization process for viscoelastic biopolymers
Inventor: EYAL DROR
IPC: C08B37/00
Filed: 2008-11-12
Granted: 2013-05-16
Abstract: Manufactured hyaluronic acid products are used in numerous surgical applications including viscoelastic supplementation for the treatment of osteoarthritis, however, traditional sterilization techniques result in the breakdown of such high molecular weight viscoelastic biopolymers and are thus unsuitable. Disclosed are processes for obtaining concentrated sterile solutions of high molecular weight biopolymers such as hyaluronic acid. The processes include filter sterilization with a dilute preparation of the biopolymer, and concentration of the dilute filter sterilized biopolymer by ultrafiltration to a desired concentration.
Patent AU-2008328637-B2 (AU)
Title: Method and arrangement for monitoring and presenting the status of an electrolytic process in an electrolytic cell
Inventor: NORDLUND LAURI
IPC: G05B19/418
Filed: 2008-11-19
Granted: 2013-07-11
Abstract: The invention relates to an arrangement and method for monitoring and presenting the status of an electrolytic process in an electrolytic cell (1). The arrangement is characterized by a return channel arrangement (8) for transmitting status information, established by the data processing means (7) of a data processing device (6) and describing the status of the electrolytic process in the electrolytic cell (1), from the data processing device (6) to an indicator device (9) arranged in connection with the electrolytic cell (1). The indicator device (9) comprises first presentation means (10) for presenting the status information established by the data processing means (7) of the data processing device (6) and describing the status of the electrolytic process in the electrolytic cell (1). The indicator device (9) is arranged to receive the status information established by the data processing means (7) of the data processing device (6) and to present said status information established by the data processing means (7) of the data processing device (6) describing the status of the electrolytic process in the electrolytic cell (1) by the first presentation means (10).
Patent AU-2009208151-B2 (AU)
Title: Wheel Frame
Inventor: GUILE GRAHAM
IPC: B60B19/12
Filed: 2009-08-14
Granted: 2012-03-15
Abstract: A wheel 10 rotatable about a main axis 6A, the wheel 10 including: (a) a frame 11 including a plurality of supports 15; and (b) a series of rollers 40 radially spaced 5 from the main axis 6A and aligned with a first plane normal to the main axis 6A, each roller 40 of the series of rollers 32 mounted on a corresponding roller axle 16 extending between adjacent supports 15 of the plurality of supports, each roller 40: (i) rotatable about an axis normal to the main axis 6A; (ii) radially spaced from the main axis 6A; and (iii) having a lateral central cross-sectional diameter greater 10 than the diameter of its end portions, wherein each roller axle 16 is linear and integral with said supports 15 to form a continuous ring of material about the periphery of the frame 11. Figs. 1, 4 and 5
Patent AU-2009251437-B2 (AU)
Title: Compounds including an anti-inflammatory pharmacore and methods of use
Inventor: JIANG XIN
IPC: C07J41/00
Filed: 2009-04-20
Granted: 2014-10-30
Abstract: This invention provides novel compounds comprising the following anti-inflammatory pharmacore Formula (I): wherein X, R
Patent AU-2009255522-B2 (AU)
Title: Monetizing remote gas using high energy materials
Inventor: KELLEY BRUCE T
IPC: C01B32/40
Filed: 2009-04-09
Granted: 2013-11-14
Abstract: The present application is directed to a method and system for monetizing energy. More specifically, the invention is directed to the economically efficient utilization of remote or stranded natural gas resources. The invention includes importing a high energy density material into an energy market and distributing the high energy density material (HEDM) therein. The HEDM is produced from reduction of a material oxide such as boria into the HEDM, which may be boron. The reduction utilizes remote hydrocarbon resources such as stranded natural gas resources.
Patent AU-2009266325-B2 (AU)
Title: Thermal gradient fluid header for multiple heating and cooling systems
Inventor: WESTON JEFFREY A
IPC: F28D20/00
Filed: 2009-07-06
Granted: 2015-07-30
Abstract: An apparatus and method for increasing efficiency of heating/cooling systems in buildings and other facilities. An elongate pipe filled with water or other fluid medium forms a thermal gradient header having temperature zones that are progressively warmer towards one end and cooler towards the other. The heating/cooling systems are connected to the header so as to draw circulating fluid from zones that are closest in temperature to the optimal intake temperature of each system, and to discharge fluid back to the header at zones that are closest to the temperature to the optimal output temperature of each system. The heating/cooling systems may be, for example, air conditioning systems, water heating systems, ice making systems, and so on; the facility may be a single building or comprise multiple buildings. The pipe forming the thermal gradient header may be routed back and forth in the facility to define a series of legs at different temperatures, with the intake and output lines of each system being connected to that leg having the temperature closest to optimum. Additional lines and control valves may enable the systems to draw from/discharge to different legs under different operating conditions, such as at different seasons. The system maximizes efficiency by allowing each system to take advantage of the thermal output of other systems. A boiler or other source of makeup heat may be connected to the thermal gradient header if necessary, and any excess heat may be supplied from the header a thermal ground field for later use or may be rejected as necessary.